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INTRODUCTION
The challenges of identifying potential 
cancer in primary care are well 
documented:1 GPs may see around 12 
cases of cancer each year but consult 
patients with symptoms associated with 
cancer on a daily basis.1 These symptoms 
are usually caused by benign and often self-
limiting illness. GPs need to decide whether 
the symptoms presented justify a referral 
for specialist investigation. The UK National 
Institute for Health and Care Excellence 
(NICE) guidelines for referral for suspected 
cancer2 recognise the role of the patient 
in the referral decision-making process, 
and emphasise that patients being referred 
with suspected cancer should be told ‘they 
are being referred to a cancer service’.2 The 
guidelines reflect the general shift toward 
patient-centred medicine, which positions 
the patient at the heart of decision making.3 
Research on shared decision making (SDM) 
has shown, however, that it has not been 
widely adopted in UK clinical practice.4 SDM 
may not occur for a number of reasons, 
including clinicians perceiving a lack of 
consultation time and a tendency to make 
decisions about whether to incorporate 
SDM based on patient attributes, such 
as age and medical condition.5 Research 
has also highlighted that patients may 
not value the knowledge they bring to the 
consultation, and thus expect practitioners 
to drive decision making rather than engage 
in SDM themselves.6
To the authors’ knowledge, there 
have been only two studies focusing on 
patient aspects of referral from primary 
to secondary care for cancer investigation. 
Both studies were Australian and primarily 
qualitative. The earlier study7 noted that 
some participants did not think they should 
be involved in the decision about whether 
they should be referred for investigation, 
and others felt that if they did not want the 
test they would not attend the appointment, 
rather than rejecting the decision during 
the primary care consultation.7 The more 
recent study found that patients did not feel 
they had had the opportunity to engage in 
decision making about the referral and, 
crucially, lacked the information to make 
an informed decision.8 In the present study, 
in-depth interviews were conducted with UK 
patients referred by their GP for specialist 
investigation for symptoms associated with 
lung or colorectal cancer. The extent to 
which patients felt involved in the decision 
making and were aware of the reasons for 
their referral were assessed.
METHOD
The individuals interviewed were taking part 
in a larger study called The SYMPTOM 
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Abstract
Background
The challenge for GPs when assessing whether 
to refer a patient for cancer investigation is 
that many cancer symptoms are also caused 
by benign self-limiting illness. UK National 
Institute for Health and Care Excellence (NICE)  
referral guidelines emphasise that the patient 
should be involved in the decision-making 
process and be informed of the reasons for 
referral. Research to date, however, has not 
examined the extent to which these guidelines 
are borne out in practice.
Aim
To assess the degree to which patients are 
involved in the decision to be referred for 
investigation for symptoms associated with 
cancer and their understanding of the referral.
Design and setting
Qualitative interview study of patients referred to 
secondary care for symptoms suspicious of lung 
and colorectal cancer. Patients were recruited 
from two regions of England using maximum 
variation sampling.
Method
Transcribed interviews were analysed 
thematically.
Results
The analysis was based on 34 patient interviews. 
Patients in both symptom pathways reported 
little involvement in the decision to be referred 
for investigation. This tended to be accompanied 
by a patient expectation for referral, however, to 
explain ongoing and un-resolving symptoms. It 
was also found that reasons for referral tended 
to be couched in non-specific terms rather than 
cancer investigation, even when the patient was 
on a cancer-specific pathway.
Conclusion
GPs should consider a more overt discussion 
with patients when referring them for further 
investigation of symptoms suspicious of cancer. 
This would align clinical practice with NICE 
guidelines and encourage more open discussion 
between GPs and primary care patients around 
cancer. 
Keywords
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cancer; primary health care; qualitative 
research; referral and consultation 
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Study.9 The SYMPTOM Study recruited 
patients aged ≥40 years, who had been 
referred to secondary care, and who 
had been identified by research nurses 
as having one of a number of specified 
respiratory and lower gastrointestinal 
(GI) symptoms potentially associated with 
lung and colorectal cancer, respectively. 
Recruitment was from secondary care 
sites in the east and north eastern regions 
of England. Some patients in the north 
East were also recruited from a tertiary 
referral centre for people with respiratory 
symptoms, which received referrals from 
all the general hospitals in the region. 
Patients had been referred via two main 
pathways. The first was the fast-track, 
2-week wait (2WW) route, whereby patients 
were expected to be seen by a cancer 
specialist within 2 weeks of referral, for 
which the patient would normally have met 
the symptom-based referral criteria in the 
NICE guidelines.2 The second route was 
via referral to a routine clinic, with a longer 
waiting time, at which the patient would not 
necessarily see a cancer specialist. In The 
SYMPTOM Study, patients were asked to 
complete a questionnaire and to indicate 
their willingness to undertake an interview. 
This group of patients was purposively 
sampled for individuals to interview who 
varied in relation to age, sex, education 
level, diagnosis, and referral pathway.
A topic guide was used to ensure 
consistency across the interviews. It was 
based on the aims of both The SYMPTOM 
Study and the present study, and on the 
authors’ knowledge of literature in the areas 
of cancer, diagnostic testing, and referral. 
Questions specifically relating to the 
present study focused on decision making 
and referral, patients’ understanding of 
the referral, and patients’ experiences of 
diagnostic testing.
The patient information sheet made no 
mention of cancer or cancer pathways, and 
the issues were not raised in the interview 
unless initiated by the patient. This was 
because, although patients were referred 
with symptoms suspicious of cancer, the 
authors had no idea whether cancer had 
been discussed with them, and thus did 
not want to raise it as part of the research 
interview. Patients gave written consent to 
participate. The interviews were conducted 
between 12 January 2011 and 29 November 
2011, usually at the patient’s home, and 
lasted between 30 and 90 minutes. They 
were audiorecorded, fully transcribed, and 
anonymised. Interviews were conducted 
until data saturation was reached.
Interviewing patients with respiratory and 
lower GI symptoms allowed comparison 
of contrasting diagnostic and referral 
experiences. Patients with respiratory 
symptoms may have a chest X-ray (CXR) 
arranged by their GP in primary care; 
the findings from this strongly influence 
whether they are recommended for 
secondary care assessment by respiratory 
specialists. In contrast, after primary care 
assessment and tests, patients with lower 
GI symptoms are generally referred to 
secondary care, with colonoscopy being the 
main diagnostic test. These two pathways 
offer markedly different experiences for 
patients in terms of cancer investigation.
Data analysis
Data were analysed thematically.10 
A sample of transcripts were read and 
re-read, and an initial coding frame 
developed, applied, and refined until codes 
were agreed and applied consistently. The 
full data set was then coded using Atlas.
ti (version 5.5) to aid data organisation and 
analysis. Coded data were organised into 
themes generated inductively, although the 
nature of the topic guide and the focus of 
the research brought a degree of deductive 
analyses to the process. Each interview 
was read and flow charts were constructed 
detailing patient pathways from symptom 
recognition, to referral, and on to secondary 
care investigation. All coded data were 
cross-referenced against the charts to 
contextualise and validate the meaning of 
the interview data. Because of the different 
characteristics of the two diagnostic 
pathways, they were analysed separately, 
then compared to identify similarities and 
differences.
RESULTS
Of the SYMPTOM responders, 1108 indicated 
that they were willing to be interviewed 
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How this fits in
When referring patients for cancer 
investigation, the National Institute for 
Health and Care Excellence (NICE)  
recommends patient involvement in 
decision making and patients being given a 
full description of the referral pathway. No 
research to date has explored the extent to 
which patients feel involved and informed 
during the referral process. The present 
study indicates that current practice is not 
closely aligned to NICE in either of these 
areas. It is suggested that there is scope 
for GPs to increase patient involvement 
and engage in a more open and explicit 
dialogue about the referral pathway.
(765 respiratory and 343 lower GI). From 
this group, 40 patients were purposively 
selected and interviewed. The analysis, 
however, was based on 34 transcripts 
(Table 1). Five transcripts were excluded 
because, although the patients met the 
selection criteria for interview, it was not 
possible to untangle their referral pathway 
relating to symptoms suspicious of cancer, 
as they had complex multiple morbidities 
and multiple points of contact with 
healthcare providers. A further transcript 
was excluded because the individual had 
undergone initial diagnostic testing and 
diagnosis abroad, and so the account did 
not detail UK clinical practice. 
Findings for each diagnostic pathway are 
presented according to two themes: patient 
involvement in the referral decision for 
diagnostic testing and/or secondary care 
assessment; and information provided and 
discussed at the time of referral. Data that 
show the impact of the referral dialogue on 
the patient experience are then detailed.
Patient involvement in decision making: 
lower GI symptoms
Most patients in this group described 
their GP as taking the decision to refer 
them. Patients did not view this negatively; 
decisions were seen to be made on their 
behalf by ‘trusted’ ‘experts’:
‘I trusted her, so if she said I needed the 
test then I needed the test, yeah, I would 
do anything that Dr [X] said.’ (P31, lower GI; 
2WW; diagnosis not known at interview) 
' I felt like she was acting in my best 
interests, so, I’m sure if I’d decided I didn’t 
like the idea I could have said "No".' (P27, 
lower GI; 2WW; diagnosis — not cancer)
Also, for some patients, referral for 
further investigation represented the 
course of action they expected or wanted:
 'The doctor thought that perhaps it could be 
piles but they wanted it checked out dear, 
which is what I wanted as well … And if they 
hadn’t of suggested [that] I would have said 
"Well look I am bleeding and I would like it 
looked further into". ' (P1, lower GI; routine; 
diagnosis not known at interview)
There was greater evidence of 
involvement when expectations were not 
met. In the following data, the patient 
describes her efforts to redirect the GP 
away from previous diagnostic suggestions:
'Well, I thought [a physical examination] 
might not be a good idea because it was, 
she might get the wrong impression, she 
might think the [stool] flatness is down 
to the piles or something, and I knew 
it wasn’t, because sometimes I feel like 
these doctors they don’t really listen, you 
know? So I think I was trying to stress the 
point that I knew what was, something 
was wrong, and that it wasn’t down to the 
piles and … Like before when they’d said 
‘anal fissure’, I accepted that then, but 
afterwards I wondered whether I should 
have accepted that as that doctor just saying 
that, you know, and I think I had mentioned 
blood in between, when we’ve mentioned 
going to other appointments, I think I might 
have mentioned blood, but they can be 
dismissive of these things, so I was being 
really definite about my symptoms on that 
occasion.' (P27, lower GI; 2WW; diagnosis 
— not cancer)
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Table 1. Participant characteristics at time of interview
  Lower GI  Respiratory 
Interviewees, n = 34 Total symptoms  symptoms 
Sex 
 Male  18 10 8 
 Female 16 9 7
Age, years 
 <50 7 4 3 
 50–59 8 4 4 
 60–69 11 8 3 
 ≥70 8 3 5
Referral type  
 2-Week Wait (2WW) 17 8 9 
 Routine  12 7 5 
 Routine (urgent)a 3 3 0 
 Tertiary b  1 0 1 
 Missing data 1 1 0
Education 
 Degree 12 6 6 
 A level/diploma/professional/ vocational 13 9 4 
 GCSE/O level 2 1 1 
 None/unknown 7 3 4
Ethnic group 
 White British 31 18 13 
 White other  1 0 1  
  Pakistani 1 1 0 
 Black African  1 0 1
Diagnosis at interview 
 Cancer 3 1 2 
 Not cancer 15 9 6 
 Diagnosis not known at interview 16 9 7
Interview 
 Mean time, days, from referral to interview c 64.2 73.1 52.8 
aGPs did not use a formal 2WW pathway but identified the referral as requiring urgent attention. bPatient 
admitted to secondary care after a chest X-ray and subsequently referred to tertiary respiratory clinic. cn = 32, 
two patients missing data.
Having been ‘definite’ about her 
symptoms, this patient was referred.
A more inclusive patient experience was 
identified, however. This was underpinned 
by GPs responding to patient concerns 
about persistent symptoms and/or giving 
patients the opportunity to voice their 
concerns. In the following quote, the patient 
describes the GP’s referral decision after 
his expression of concern about cancer:
'We talked about my bowel movements 
and she said "is there anything that you’re 
actually worried about?" I said "well yeah, 
cancer is the word you see", "okay", she 
said "well let’s take it a stage further", so 
she arranged for me to have a blood test 
to check my um, whatever it is, PSA, for 
the prostate, she said "and we’ll see about 
getting you in to see, for an endoscopy for 
your issues with your bowel", and that was 
it.' (P23, lower GI; 2WW; diagnosis — not 
cancer)
The referral dialogue: lower GI symptoms
Many patients recalled a vague and non-
specific account of the reasons for referral, 
even when a 2WW appointment had been 
made. These patients tended not to see this 
as problematic:
'He just said "we’ll see what they find", 
because I don’t think he wants, he wanted 
to like um, get me to dwell on what it might 
be and what it, you know, because some 
people do, it’s like having the internet isn’t 
it, you’ve got an ache and you’re looking up 
on Google and you end up you’ve got Calvin 
syndrome and whatever haven’t you, you 
know?' (P43, lower GI; 2WW; diagnosis — 
not cancer)
'Dr [X], she said to me "I’m going to have this 
checked out at hospital", and I said "Right" 
and she said "The hospital will be in contact 
in the next 7 to 14 days" she said "And we’ll 
just double check". And I said "Right, okay" 
I don’t think I asked any questions of Dr 
[X] and I don’t think she gave any, and I’ll 
explain why. Dr [X]’s a fantastic doctor and 
I’d trust her with my life.' (P31, lower GI; 
2WW; diagnosis — not cancer)
The dialogue was often accompanied by a 
narrative of reassurance and safety-netting:
'She said "I don’t think there’s anything to 
worry about" she said "But we’ve obviously 
got to have the bleeding investigated" (P31, 
lower GI; 2WW; diagnosis — not cancer)
It was rare that patients reported GPs 
introducing the possibility of cancer or 
explaining the investigations in terms of 
testing for cancer. In the few cases where 
cancer was discussed, patients described 
GPs emphasising the safety-netting aspect 
of the decision, that is, to rule out cancer 
rather than to find it:
' I think the last time I went to see her she 
did say "Obviously you are concerned", 
and I said "Well I’m bound to be concerned 
because I value my health and I know 
when there’s something wrong with me", 
and she said "Right, I’m not saying that 
it’s cancer, I’m not saying that it isn’t 
cancer, because I can’t say until you have 
all these tests, that’s why I’m sending 
you for all these tests to find out", she 
said "Ticking things off to find out what is 
actually wrong with you. Obviously there’s 
something wrong because you’re feeling 
like this". So it was just like a ticking box 
really, ticking things off, you know, that’s 
clear, that’s clear.' (P29, lower GI; routine; 
diagnosis — not cancer)
A dialogue around cancer also entered 
the consultation from patients concerned 
their symptoms were caused by cancer. 
Again, the GP was reported as describing 
the investigation in non-specific terms and 
minimising the possibility of cancer:
'I said "I hope it’s not cancer or anything 
like that’ and he said, ‘oh no, no’, he said 
"It’s just a routine check done in 5 minutes 
and I’ll get the results 24 hours later" (P24, 
lower GI; routine; diagnosis — not cancer)
Patient involvement in decision making: 
respiratory symptoms
For patients with respiratory symptoms the 
decision to refer to secondary care tended 
to follow a CXR in primary care (some are 
referred direct to secondary care if they 
have overt high-risk cancer symptoms). 
This CXR played a highly significant role 
in shaping the patients’ referral and 
investigative pathway, as it is recognised as 
‘the best first line test for suspected lung 
cancer’.11
Most patients recalled the CXR as part 
of a general investigation and something 
they expected given their symptoms. At this 
stage, GPs did not tend to introduce the 
issue of cancer either:
' I mean, he just examined me and said I 
needed an X-ray, could tell from tapping my 
chest that there was something not right. 
... Just that he’d diagnosed something 
that needed to be explored really.' (P17, 
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respiratory; tertiary; diagnosis — cancer)
Most patients did not feel directly involved 
in the decision to have a CXR but the test 
was seen as routine and the next ‘logical’ 
step to be taken:
' It was entirely his [decision], I’d never 
even considered it.' (P36, respiratory; 2WW; 
diagnosis — not cancer)
As with the lower GI patients, patients 
expected the GP to take an action that 
would represent progress and the notion 
of patient involvement was not relevant to 
them. Indeed, when invited by their GP to 
comment, some patients found it strange:
' Yeah, he asked if I minded and I thought 
"well why would I mind?" I’d rather sort of 
if there is something going on, I’d rather 
know than sort of hide my head but he 
did say "I think I’m going to send you for 
a chest X-ray, do you mind?" So, which I 
found really strange.' (P38, respiratory; 
routine; diagnosis — not cancer)
This sense of GP decision making 
endorsing patient expectations was also 
evident in the way that patients saw the 
referral decision as a positive step, in that 
it indicated both they and their symptoms 
were being taken seriously:
' [On being sent for CXR] A mixture of, again, 
pleasure that, pleasure, wrong word, you 
know, satisfaction that I was being taken 
seriously and given a test that made sense, 
and should obviously be done and sort 
of slight hesitation about why that would 
be necessary.' (P14, respiratory; 2WW; 
diagnosis — cancer)
The referral dialogue: respiratory 
symptoms
After CXR, patients reported that referrals 
to secondary care on a 2WW pathway were 
not always accompanied by a discussion of 
the reasons for referral but tended to be of 
a general and non-specific nature:
' Having had the X-ray, I got a phone call 
on the Friday from the doctor, to say 
that he got the results back and that I 
needed to go to a hospital and did I want 
to go to [hospital 1] or [hospital 2]. After 
discussion we chose [hospital 2]. So clearly 
he could see something on the X-ray that 
needed attention.' (P17, respiratory; 2WW; 
diagnosis — cancer)
'Just that there was this patch on the 
lung that was showing up and that he 
wanted me to go and see the specialist 
when they would take another photo, you 
know, another X-ray, and if it cleared up, 
fair enough. If it hadn’t you know, they 
would decide what to do. I think that was 
around with all the blood tests were clear, 
no problem with them.' (P36, respiratory; 
2WW; diagnosis — not cancer)
'Nothing, just, no all he said was the lung 
health clinic. He said "you’re going to the 
lung health clinic" so … No, he didn’t do 
anything at all. Oh he had a listen at my 
chest and the old tapping bits, just, but 
nothing else ... Well as I say when I got this 
little lump on the chest he said "right, you’re 
in".' (P33, respiratory; 2WW; diagnosis — 
not cancer)
For patients referred to secondary care 
for routine appointments, the dialogue 
tended to revolve around the theme of 
no further investigations being available in 
primary care: 
' And then he said "I don’t know what to do 
with you so I'd better refer you to the lung 
clinic" he said "this is not good and this has 
been going on for such a long time so we’ll 
refer you there". (P12, respiratory; routine; 
diagnosis — not cancer)
The referral dialogue: impact (lower GI 
and respiratory)
It was clear from the data that patients’ 
experiences of referral in both investigative 
pathways were positive and generally 
followed an expected path. There were 
negative outcomes, however, from this type 
of referral.  Many patients entered secondary 
care assessment on a 2WW pathway with 
symptoms suspicious of cancer having not 
had a substantive discussion with their GP 
about the possibility of cancer. The 2WW 
pathway moves events very quickly, and 
it was apparent that the lack of a clear 
explanation at the point of referral could 
lead to feelings of uncertainty and anxiety:
'The fact that they’d bothered to ring up 
and get me in early, that began to ring a 
few alarm bells. There must be something 
there that makes it important that we 
short-circuit the system that the doctor had 
set up.' (P14, respiratory; 2WW; diagnosis 
not known at interview)
'I think, because I was a bit concerned about 
the speed that this was going through, you 
know, I thought "well I’d only gone with 
a little pain, why is he sending me to see 
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consultants and chest X-rays and things"... 
you know, I’ve got a slight pain down here, 
why are they sending me for a chest X-ray?.
So I suppose I was a bit, you know, I was a 
bit concerned as to why everything seemed 
to go through at a fairly rapid pace.' (P36, 
respiratory; 2WW; diagnosis not known at 
interview)
The next quote highlights the potential 
practical and ethical issues that arise when 
patients are not given an explanation for 
their referral. The patient recalls seeing her 
details on the computer screen, prior to her 
secondary care appointment:
'I was looking at the screen, they don’t 
actually say it, but I was reading on the 
screen it said ‘cancer referral’ now nobody 
had said that to me, and I was looking at it 
and that made me upset when I saw it on 
the screen … it was a bit scary and I was 
already upset, so I got really upset.' (P27, 
lower GI; 2WW; diagnosis not known at 
interview)
The next extract illustrates the paradox 
and confusion that can arise between 
the wider macrosphere of public health 
campaigning and the microsphere of the 
GP consultation. Although the present data 
highlight a minimisation of cancer dialogue 
where patients exhibit potential cancer 
symptoms, at the same time there are 
public health campaigns running12 that try 
and raise awareness of cancer symptoms 
and encourage a dialogue between patients 
and their GPs around cancer, without fear 
and embarrassment:
 'You see, on the internet, when you find all 
these things, they say "Oh, go to your doctor 
immediately blah de blah" but the response 
you get when you go to the doctor is to tell 
you "Oh, it’s only this, it’s only that, only an 
anal fissure" or something, you know what I 
mean? So it’s different, it doesn’t match up.' 




Data from the present study indicate 
that patients’ experiences of referral for 
cancer investigation are some way from 
NICE referral guidance, in terms of 
patient involvement in decision making 
and communication about the reasons for 
referral. It is suggested that patients had a 
minimal role in decision making. In many 
cases, their expectations were met by the 
GPs’ decisions and they saw referral as a 
progression rather than a decision. 
Patient accounts of the primary care 
consultations indicated a tendency for GPs 
to keep referral dialogue non-specific, 
without an overt discussion about the 
possibility of cancer, even when it was a 
2WW referral. Having sampled across a 
number of different patient attributes (for 
example, age and sex) and across two 
different referral pathways, and compared 
participants’ accounts, it was found that 
issues identified around patient involvement 
and communication were common across 
patient groups and pathways.
Strengths and limitations
Only patients referred for investigation were 
interviewed. To get a fuller perspective of 
this process, future research could look at 
the perspectives of patients presenting with 
similar symptoms who are not referred, 
and video or audiorecord the consultation 
itself to capture how different individuals 
and perspectives interact. Also, patients in 
secondary care were interviewed, and so 
there was a passage of time between their 
referral and the interviews. Ideally patients 
would have been interviewed immediately 
after referral to avoid recall bias and the 
possibility of post hoc reconstruction. 
However, to the authors’ knowledge, the 
study is the first to examine GP–patient 
communication around referral for 
cancer investigation. This is quite striking 
considering the prominence the NICE 
cancer referral guidelines give to patient 
involvement and communication.
Comparison with existing literature
In terms of SDM, it appeared that participants 
did not recognise the point of referral as 
warranting their involvement. In addition, 
the data suggest that some practitioners 
did not try to encourage an open discussion. 
This could be because clinicians may make 
a priori decisions about the appropriateness 
of SDM based on time, clinical condition, 
and patient characteristics.5 In relation to 
the wider literature on cancer diagnosis in 
primary care, research has highlighted the 
primary care consultation as a particular 
sticking point in the diagnostic pathway for 
cancer13 and as having significant potential 
for reducing the diagnostic interval14 (the 
period between presentation to a clinician 
and diagnosis).15 Qualitative studies have 
identified issues around communication 
that contribute to such delays, for example, 
patients expressing guilt about presenting 
their symptoms and ‘wasting’ the GP’s 
time,16 and normalising symptoms, which 
prevented disclosure during consultations.17 
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Although the focus of the study was not 
delay in symptom presentation, the findings 
resonate with these studies in highlighting 
a difficulty that cancer, or in this case, the 
possibility of cancer, appears to inhibit or 
block open and clear communication about 
the meaning of symptoms.
Implications for practice
It is known that GP referral for specialist 
investigation is determined by social 
interaction as well as clinical information,18 
and one of the key social characteristics of 
cancer is the fear that it generates.19 Thus 
a GP referring a patient with symptoms 
indicating risk levels around 5% (most 
NICE-based symptoms are at or above 
this level of risk)20 may withhold discussion 
about cancer because they do not want 
to raise patient anxiety, and it is known 
that patients can find being referred for 
cancer particularly stressful;2 furthermore, 
it is worth remembering that GPs generally 
manage a higher level of risk than their 
secondary care colleagues.18 The present 
data indicate, however, that the ‘tipping 
point’ for discussing cancer alongside 
referral for investigation could be set too 
high. It is suggested that the tipping point 
for discussing the possibility of cancer 
should be moved to a lower level of risk for 
the following reasons:
• the importance of patient involvement 
in decision making and health care is 
recognised by the NHS as a core value.21 
The present data illustrate the problems 
that can occur when a full dialogue about 
the referral is withheld.
• currently there are public health cancer 
awareness campaigns22 that encourage 
attendance in primary care for what 
patients may perceive as everyday 
ailments, albeit they have persisted 
for longer than usual. The message is 
that it is appropriate to discuss these 
symptoms and the possibility of cancer 
with the GP. The present data suggest 
that there is a discrepancy between the 
aims of the campaigns to encourage 
a cancer-based dialogue, and what is 
happening in clinical practice.
Funding
This study presents independent research 
funded by the National Institute for Health 
Research (NIHR) Programme Grants for 
Applied Research programme, RP-PG-
0608-10045. The views expressed are those 
of the authors and not necessarily those 
of the NHS, the NIHR or the Department 
of Health. The funders of this study had 
no role in: study design; data collection, 
analysis, and interpretation; or the writing 
of this research.
Ethical approval
Ethical approval was granted by the 
Cambridgeshire 3 Research Ethics 
Committee (10/H0306/50).
Provenance
Freely submitted; externally peer reviewed.
Competing interests
William Hamilton is the clinical lead for the 
ongoing revision of the NICE 2005 guidance 
on suspected cancer. His contribution to this 
article is in a personal capacity, and is not to 
be interpreted as representing the view of 
the Guideline Development Group, or of NICE 
itself. The remaining authors have no conflict 
of interest relevant to this research.
Acknowledgements
The authors would like to acknowledge 
the contribution of all the patients who 
participated in this research. We are also 
grateful for the contribution made by the 
Discovery Programme Steering Committee 
comprising: Roger Jones (chair); Clare 
Bankhead; Alison Clutterbuck; Jon Emery; 
Ardiana Gjini; Joanne Hartland; Maire 
Justice; Jenny Knowles; Helen Morris; 
Richard Neal; Peter Rose; Greg Rubin. We 
would like to thank: Helen Morris for her role 
in managing the SYMPTOM Study, including 
planning and coordinating recruitment of 
the patients for the research in this paper; all 
the nurses, doctors and administration staff 
at the participating hospitals (Addenbrooke’s 
Hospital, Cambridge; Papworth Hospital, 
Cambridge; University Hospital of North 
Durham; Darlington Memorial Hospital 
and University Hospital of North Tees) who 
facilitated participant recruitment. 
Discuss this article
Contribute and read comments about this 
article: bjgp.org/letters
REFERENCES
1. Hamilton W. Cancer diagnosis in primary care. Br J Gen Pract 2010; 60(571): 
121–128.
2. National Institute for Health and Care Excellence. Referral guidelines for 
suspected cancer. NICE guidelines [CG27], June 2005 .https://www.nice.org.
uk/guidance/cg27 (accessed 07 Nov 2014).
3. The Health Foundation. Helping people share decision making: a review of 
evidence considering whether shared decision making is worthwhile. London: 
The Health Foundation, 2012.
4. Coulter A, Collins A. Making shared decision-making a reality: no decision 
about me, without me. http://www.kingsfund.org.uk/sites/files/kf/Making-
shared-decision-making-a-reality-paper-Angela-Coulter-Alf-Collins-
July-2011_0.pdf (accessed 07 Nov 2014).
5. Legare F, Ratte S, Gravel K, Graham ID. Barriers and facilitators to 
implementing shared decision-making in clinical practice: update of a 
systematic review of health professionals’ perceptions. Patient Educ Couns 
2008; 73(3): 526–535.
6. Joseph-Williams N, Elwyn G, Edwards A. Knowledge is not power for 
patients: a systematic review and thematic synthesis of patient-reported 
barriers and facilitators to shared decision making. Patient Educ Couns 2014; 
94(3): 291–309.
7. Davey HM, Lim J, Butow PN, Barratt AL, Redman S. Women’s preferences 
for and views on decision-making for diagnostic tests. Soc Sci Med 2004; 58: 
1699–1707.
8. Pascoe SW, Veitch C, Crossland LJ, et al. Patients’ experiences of referral for 
colorectal cancer. BMC Fam Pract 2013; 14: 124.
9. L Birt, N Hall, K Mills, J Banks, J Emery, M Johnson, FM Walter. Responding 
to symptoms suggestive of lung cancer: a qualitative interview study. BMJ 
Open Respiratory 2014; (in press).
10. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 
2006; 3(2): 77–101.
11. Department of Health. Direct access to diagnostic tests for cancer: best 
practice referral pathways for general practitioners. https://www.gov.uk/
government/publications/direct-access-to-diagnostic-tests-for-cancer-best-
practice-referral-pathways-for-general-practitioners (accessed 07 Nov 2014).
12. Public Health England. Be clear on cancer. http://campaigns.dh.gov.uk/
category/beclearoncancer (accessed 16 Oct 2014).
13. Vedsted P, Olesen F. Are the serious problems in cancer survival partly 
rooted in gatekeeper principles? An ecological study. Br J Gen Pract 2011; 
DOI: 10.3399/bjgp11X588484.
14. Allgar VL, Neal RD. Delays in the diagnosis of six cancers: analysis of data 
from the National Survey of NHS Patients: Cancer. Br J Cancer 2005; 92(11): 
1959–1970.
15. Walter F, Wester A, Scott S, Emery J. The Andersen Model of Total Patient 
Delay: a systematic review of its application in cancer diagnosis J Health Serv 
Res Policy 2012; 17(2): 110–118.
16. Smith LK, Pope C, Botha JL. Patients’ help-seeking experiences and delay 
in cancer presentation: a qualitative synthesis. Lancet 2005; 366(9488): 
825–831.
17. Brindle L, Pope C, Corner J, Leydon G, Banerjee A. Eliciting symptoms 
interpreted as normal by patients with early-stage lung cancer: could GP 
elicitation of normalised symptoms reduce delay in diagnosis? Cross-
sectional interview study. BMJ Open 2012; 2(6).
18. Morgan M, Jenkins L, Ridsdale L. Patient pressure for referral for headache: 
a qualitative study of GPs’ referral behaviour. Br J Gen Pract 2007; 57(534): 
29–35.
19. Cancer Research UK. CancerStats Key Facts. http://www.cancerresearchuk.
org/cancer-info/cancerstats/keyfacts/cancerstats-key-facts-on-cancer 
(accessed 16 Oct 2014).
20. Shapley M, Mansell G, Jordan JL, Jordan KP. Positive predictive values of 
≥5% in primary care for cancer: systematic review. Br J Gen Pract 2010; DOI: 
10.3399/bjgp10X515412.
21. Department of Health. Equality and excellence: Liberating the NHS. London: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/
file/213823/dh_117794.pdf (accessed 16 Oct 2014).
22. Cancer Research UK. About be clear on cancer. 2014. http://www.
cancerresearchuk.org/cancer-info/spotcancerearly/naedi/beclearoncancer/
background (accessed 23 Oct 2014).
British Journal of General Practice, December 2014  e782
